As an official supporting sponsor, Theragenics will have a major interactive presence at the majority of BASS events on the CITGO Bassmaster Tournament Trail, including the CITGO Bassmaster Elite Series, the Bassmaster Majors and the CITGO Bassmaster Classic.
The agreement also includes a large presence across BASS’ multi-media assets. Beginning this month and throughout the 2006 BASS season, Theragenics will air a television spot featuring BASS Elite pro Rick Clunn nationally on ESPN networks, as well as in several local markets.
To further support the sponsorship, Theragenics has invited Clunn to promote the Company’s consumer education message – “know your options for prostate cancer treatment.”
"We are pleased Theragenics chose to make BASS part of their awareness campaign,” said Don Rucks, vice president and general manager of BASS. “We applaud the vision of Theragenics in recognizing the significance of the brand-loyal BASS members and fans."
TheraSeed®, a prostate cancer treatment device manufactured by Theragenics, produces cure rates better than or equal to surgery. The minimally invasive outpatient procedure offers faster healing times than surgery and works with a lower risk of incontinence and impotence.
“We have a message for men with prostate cancer – know your options before you commit to any treatment. This partnership gives us a great opportunity to reach BASS fishing fans across the country,” said M. Christine Jacobs, president and CEO of Theragenics. “This campaign is all about our dads, brothers and husbands."
Theragenics and BASS have worked closely together to develop an integrated platform that will resonate with members and fans, and raise more awareness about this disease and proven treatment options. It includes:
§ Signage: Beginning at the 2006 CITGO Bassmaster Classic in Kissimmee, Theragenics and its TheraSeed brand will have a strong signage presence as an official supporting sponsor of BASS tournaments. This includes signage at all of the ESPN- and ESPN2- televised tournaments.
§ The Blue Ribbon Program: Theragenics will reach BASS fans at tournaments by distributing blue ribbons and literature to raise awareness about prostate cancer and its proven treatment options.
§ National ‘Fish with your Dad Month’ program: Theragenics and BASS will work to create this program that will take place in September 2006 and coincide with Prostate Cancer Awareness Month.
§ Presenting ‘The Rock’: Theragenics will be the presenting sponsor of “The Rock,” the final stop on the CITGO Bassmaster Elite Series trail, Sept. 14-17 on Table Rock Lake in Kimberling, Mo.
About BASS BASS is the worldwide authority on bass fishing, sanctioning more than 20,000 events through the BASS Federation annually. Guided by its mission to serve all fishing fans, BASS sets the standard for credibility, professionalism, sportsmanship and conservation, as it has for nearly 40 years.
BASS stages bass fishing tournaments for every skill level and culminates with the CITGO Bassmaster Classic. Through its clubs, youth programs, aquatic resource advocacy, magazine publishing and multimedia platforms, BASS offers the industry’s widest array of services and support to its nearly 550,000 members. The organization is headquartered in Celebration, Fla.
For more information, contact BASS Communications at (407) 566-2208 or visit www.bassmaster.com.
About Theragenics Theragenics Corporation (NYSE: TGX) is a provider of brachytherapy and surgical products. In Buford, Ga., the Company manufactures and markets its premiere product, the palladium-103 TheraSeed device (www.theraseed.com), and I-Seed, an iodine-125 based device, which are used primarily in the minimally invasive treatment of localized prostate cancer. Theragenics is the world's largest producer of palladium-103 for human use. Through its subsidiary, CP Medical (www.cpmedical.com), based in Portland, Ore., the Company manufactures and distributes medical products for diverse surgical markets including wound closure, cardiac pacing, and the general, dental, cosmetic and veterinary markets. For additional information, call the Company's Investor Relations Department at (800) 998-8479 or visit www.theragenics.com.